Severity of Epilepsy and Response to Antiseizure Medications in Individuals With Multiple Sclerosis: Analysis of a Real-World Dataset
This study supports the notion that individuals with MS + E can have more severe epilepsy than those with E – MS. Seizure severity among individuals with MS + E treated with sodium channel blockers/modulators vs other ASM classes shows no significant differences.
Classification of Evidence
This study provides Class III evidence that individuals with MS + E can have more severe epilepsy than those with E – MS.
Source: Neurology Clinical Practice - Category: Neurology Authors: Villamar, M. F., Sarkis, R. A., Pennell, P., Kohane, I., Beaulieu-Jones, B. K. Tags: All Health Services Research, Multiple sclerosis, All epidemiology, All Epilepsy/Seizures, Antiepileptic drugs Research Article Source Type: research
More News: Brain | Epidemiology | Epilepsy | Health Management | Hospitals | Multiple Sclerosis | Neurology | Sodium | Study